Yarrow Bioscience (YARW) Inventory (2019 - 2021)

Yarrow Bioscience (YARW) has reported Inventory for 3 consecutive years, with $7.3 million the latest figure, recorded in Q4 2021.

• For the quarter ending Q4 2021, Inventory fell 1.53% year-over-year to $7.3 million; the trailing twelve-month figure through Dec 2021 stood at $7.3 million (down 1.53% YoY), and the FY2021 full-year result was $7.3 million, down 1.53% from the prior year.
• Inventory declined to $7.3 million in Q4 2021 per YARW's latest filing, from $8.1 million in the prior quarter.
• Across five years, Inventory topped out at $8.3 million in Q2 2021 and bottomed at $1.4 million in Q4 2019.
• Historically, Inventory has averaged $6.2 million across 3 years, with a median of $7.3 million in 2021.
• The sharpest annual moves came in 2020 and 2021: Inventory soared 446.02% in 2020, then slipped 1.53% in 2021.
• Over 3 years, Inventory stood at $1.4 million in 2019, then jumped by 446.02% to $7.4 million in 2020, then slipped by 1.53% to $7.3 million in 2021.
• According to Business Quant data, Inventory over the past three periods registered $7.3 million, $8.1 million, and $8.3 million for Q4 2021, Q3 2021, and Q2 2021 respectively.